A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration

Cell Cycle

Volumn 8, Issue 8, 2009, Pages 1228-1237

  Ierano, Caterina ^a   Giuliano, Paola ^a   D'Alterio, Crescenzo ^a   Cioffi, Michele ^a   Mettivier, Valentina ^a   Portella, Luigi ^a   Napolitano, Maria ^a   Barbieri, Antonio ^a   Arra, Claudio ^a   Liguori, Giuseppina ^a   Franco, Renato ^a   Palmieri, Giuseppe ^b   Rozzo, Carla ^b   Pacelli, Roberto ^c   Castello, Giuseppe ^a   Scala, Stefania ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

^c CNR   (Italy)

Author keywords

AMD3100; Chemokine receptor; Chemotactic factor; Chemotaxis; Colon cancer; CXC chemokine receptor; CXCL12; CXCR4; ERK; G protein coupled receptor (GPCR); Gi subfamily; Melanoma; pERK

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MITOGEN ACTIVATED PROTEIN KINASE 1; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL GROWTH; CELL MIGRATION; COLON CARCINOMA; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA CELL; MOUSE; MUTANT; NONHUMAN; POINT MUTATION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; WILD TYPE;

EID: 65949095206     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.8.8250     Document Type: Article

References (37)

1. + progenitors to peripheral blood. J Exp Med 1997; 185:111-120
2. Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, Stadel JM. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 1998; 273:4282-4287
3. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, et al. Impaired B-lymphopoiesis, myelopoiesis and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998; 95:9448-9453
4. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392:556-565 (Pubitemid 28207705)
5. Lataillade JJ, Clay D, Bourin P, Herodin F, Dupuy C, Jasmin C. Stromal cell derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 2002; 99:1117-1129
6. Molyneaux KA, Zinszner H, Kunwar PS, Schaible K, Stebler J, Sunshine MJ. The chemokine SDF1/CXCL12 and its receptor CXCR4 regulate mouse germ cell migration and survival. Development 2003; 130:4279-4286 (Pubitemid 37185317)
7. Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M, Kipps TJ. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cellderived factor-1. Blood 2000; 96:2655-2663
8. Zhou Y, Larsen PH, Hao C, Yong VW. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002; 277:49481-49487 (Pubitemid 36014384)
9. Geminder H, Sagi-Assif O, Goldberg L, Meshel T, Rechavi G, Witz IP. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cellderived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001; 167:4747-4757 (Pubitemid 32954357)
10. Zeelenberg IS, Ruuls-Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003; 63:3833-3839 (Pubitemid 36793074)
11. Wang J, Sun Y, Song W, Nor JE, Wang CY, Taichman RS. Diverse signaling pathways through the CXCL12/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal 2005; 17:1578-1592 (Pubitemid 41253997)
12. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 2002; 62:5930-5938 (Pubitemid 35204756)
13. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410:50-56 (Pubitemid 32225831)
14. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004; 14:171-179 (Pubitemid 38586742)
15. Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, et al. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 2005; 5:1835-1841.
16. Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, et al. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin Cancer Res 2006; 9:2795-2803
17. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 2005; 23:2744-2753 (Pubitemid 46179464)
18. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S. The chemokine, stromal cell-derived factor-1a, binds to the transmembrane G-proteincoupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 1998; 273:23169-23175 (Pubitemid 28417500)
19. Hamm HE. The many faces of G protein signaling. J Biol Chem 1998; 273:669-672 (Pubitemid 28049148)
20. Bockaert J, Fagni L, Dumuis A, Marin P. GPCR interacting proteins (GIP). Pharmacol Ther 2004; 103:203-221 (Pubitemid 39298464)
21. Tian S, Choi WT, Liu D, Pesavento J, Wang Y, An J, et al. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains. J Virol 2005; 79:12667-12673
22. Brelot A, Heveker N, Montes M, Alizon M. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities. J Biol Chem 2000; 275:23736-23744 (Pubitemid 30624660)
23. Ueda Y, Neel NF, Schutyser E, Raman D, Richmond A. Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the downregulation of cell-tocell contact, enhanced motility and proliferation in breast carcinoma cells. Cancer Res 2006; 66:5665-5675 (Pubitemid 43927119)
24. Roland J, Murphy BJ, Ahr B, Robert-Hebmann V, Delauzun V, Nye KE, et al. Role of the intracellular domains of CXCR4 in CXCL12-mediated signaling. Blood 2003; 101:399-406.
25. Teicher BA. In vivo tumor response end points. In: Teicher B, editor. Tumor models in cancer research. Totowa: Humana Press 2002; 593-616.
26. Wang J, He L, Combs CA, Roderiquez G, Norcross MA. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions. Mol Cancer Ther 2006; 10:2474-2483 (Pubitemid 44650911)
27. Labrosse B, Brelot A, Heveker N, Sol N, Schols D, De Clercq E, Alizon M. Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100. J Virol 1998; 72:6381-6388 (Pubitemid 28323949)
28. Zhang WB, Navenot JM, Haribabu B, Tamamura H, Hiramatu K, Omagari A, et al. A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists. J Biol Chem 2002; 277:24515-24521
29. Hatse S, Princen K, Gerlach LO, Bridger G, Henson G, De Clercq E, et al. Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100. Mol Pharmacol 2001; 1:164-173
30. Rosenkilde MM, Gerlach LO, Hatse S, Skerlj RT, Schols D, Bridger GJ, Schwartz TW. Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor. J Biol Chem 2007; 282:27354-27365 (Pubitemid 47501954)
31. Kawai T, Choi U, Cardwell L, DeRavin SS, Naumann N, Whiting-Theobald NL, et al. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with Cterminus-truncated CXCR4. Blood 2007; 109:78-84.
32. Busillo JM, Benovic JL. Regulation of CXCR4 signaling. Biochim et Biophys Acta 2007; 1768:952-963 (Pubitemid 46452548)
33. Schuller U, Koch A, Hartmann W, Garre ML, Goodyer CG, Cama A, et al. Subtypespecific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas. Int J Cancer 2005; 1:82-89
34. Diaz GA. CXCR4 mutations in WHIM syndrome: a misguided immune system? Immunol Rev 2005; 203:235-243
35. Scala S, Giuliano P, Ascierto PA, Ierano C, Franco R, Napolitano M, et al. Human melanoma metastases express functional CXCR4. Clin Cancer Res 2006; 8:2427-2433
36. Miller RJ, Banisadr G, Bhattacharyya BJ. CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol 2008; 198:31-38
37. Hermann PC. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 3:313-323 (Pubitemid 47355323)